Brazil’s health regulator Anvisa on Tuesday said it had approved human clinical trials for a potential COVID-19 vaccine developed by Johnson & Johnson’s pharmaceutical subsidiary Janssen. Brazil is the second-worst hit country for coronavirus cases and deaths after the United States, leading many vaccine developers to seek out clinical trials here. Brazil had registered 3.4 million cases of the disease and more than 108,000 related deaths as of Monday. …read more
Source:: Yahoo Finance
